|
|
|
|
|
| Scaling For What's Next In EMEA | Article | Cryoport Systems | Scaling cell and gene therapy operations in EMEA demands strategic planning, regulatory alignment, and robust logistics to meet growing demand and ensure consistent delivery across diverse markets. |
|
|
|
| A CRDO Path To Faster Biologic Development | Article | Dr. Ivonne Stelzl and Dr. Matthias Lucke, Coriolis Pharma | A science‑driven CRDO model accelerates biologic development by combining expert formulation, analytics, and partnerships to reduce risk and improve outcomes. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | The Jones Act punishes U.S. pharmaceutical manufacturing. It may have taken a modern-day war, one much involved with the free navigation of commercial shipping, but after more than 100 years navigating a policy of protectionism – and fear of competition – we have again waived the Jones Act (for 60 days). Chief Editor Louis Garguilo says let’s not temporarily waive it. Sink the Jones Act forever. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| The Gateway Delivery To The Brain | Article | By Justin Lygrisse, Kindeva | Nose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress. |
|
|
|
|
| Transitioning To PFS And Subcutaneous Delivery | White Paper | Catalent | Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient. |
|
|
| Soluble Versus Insoluble Expression In Microbial Fermentation | Article | By Nikolay Krumov and Jonas Mueller, Lonza | Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges? |
|
|
|
Made For What's Next In Drug Delivery | BD Medical - Pharmaceutical Systems | A global partner offering prefillable drug‑delivery systems, manufacturing expertise, and integrated services that accelerate development, secure supply, and support therapies across multiple areas. |
|
|
|
|
Accelerate Your Pipeline With CDMO Collaboration | Cytiva | A CDMO can augment your capacity and expertise, refine your processes, and ultimately shorten your time to market. Explore best practices that make working with a CDMO as efficient as possible. |
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
